Regeneron asks court to dismiss COVID-19 tech patent suit
24-08-2021
German court deals blow to Sanofi over cholesterol drug
05-06-2019
29-08-2019
Photobyphm / Shutterstock.com
A US judge yesterday, August 28 ruled in favour of Sanofi and Regeneron in the pharmaceutical companies’ long-running patent dispute with Amgen over the cholesterol drug Praluent.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Amgen, Sanofi, Regeneron, Praluent, Repatha, cholesterol, patent infringement, PCSK9